Skip to content
Disclosery

SOPHROSYNE CAPITAL LLC: GENC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of SOPHROSYNE CAPITAL LLC on GENC, newest first. How the timeline and the estimate are built.

SOPHROSYNE CAPITAL LLC held 0 GENC shares at 2015-03-31 per its 13F-HR filed 2015-04-20.

the latest 13F is the newest step

  1. period ended2015-03-31
    13F 0 shares
    Change vs previous 13F -12,150 shares

    13F-HR 0001420506-15-000216 filed by SOPHROSYNE CAPITAL LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2014-12-31
    13F 12,150 shares
    Change vs previous 13F not available

    0.18% of the 13F portfolio, value $114,000.

    13F-HR 0001420506-15-000017 filed by SOPHROSYNE CAPITAL LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).